dr. Q. (Guy ) Kwakkenbos

dr. Q. (Guy ) Kwakkenbos

Professor Emeritus
dr. Q. (Guy ) Kwakkenbos
  • Department of General Practice



Guy Rutten is professor of Diabetology in Primary Care and Director of the training-course for executives in Diabetology in primary care. His research focuses on type 2 diabetes (T2DM) and cardiovascular complications and diabetes primary care. He is (co-)author of more than 325 original articles in peer reviewed journals and supervised 13 RCTs on T2DM and wrote 10 books on diabetes, guidelines, clinical reasoning and the patient-doctor relationship. He supervised or is supervising 20 PhD students. In 2010 he distributed the book ‘Diabetes Care, from Science to Practice’, based on the scientific work of his research group, to all Dutch primary care practices (ZonMW sponsorship). He was an author of the 2013 guidelines on T2DM from the Dutch College of General Practitioners. In 2010 he was nominated for the Dutch Diabetes Research Prize. He was on the writing committee of the global NAVIGATOR study and on the Global Expert Panel of the global LEADER trial. From 2006-2008 he was Editor-in-chief of Primary Care Diabetes, from 2005-2011 he chaired the European Primary Care Diabetes Study Group and from 1996 to 2017 the Dutch Diabetes Primary Care Expert Group. He was member of the scientific Advisory Board of the Dutch Diabetes Fund(2004-2010). Besides, he worked as a GP from 1982 until 2014 for at least two days/week.

Side Activities

Member Editorial Board of Lancet Diabetes and Endocrinology
Member Editorial Board of European Endocrinology
Member of EASD Postgraduate Committee
Outside activities that could damage interests of UMC: none

Research Output (439)

Key Factors Relevant for Healthcare Decisions of Patients with Type 1 and Type 2 Diabetes in Secondary Care According to Healthcare Professionals

Ruissen Merel M., Sont Jacob K., van Vugt Heidi A., Kunneman Marleen, Rutten Guy E.H.M., de Koning Eelco J.P. 2022, In: Patient Preference and Adherence. 16 , p. 809-819 11 p.

Shared decision making in primary care:Process evaluation of the intervention in the OPTIMAL study, a cluster randomised trial

Den Ouden Henk, Vos Rimke C., Pieterse Arwen H., Rutten Guy E.H.M. 2022, In: Primary Care Diabetes. 16 , p. 375-380 6 p.

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy:Does it improve decisional conflict? Three-armed, blinded, randomised controlled trial

Jaspers Nicole E.M., Visseren Frank L.J., Van Der Graaf Yolanda, Smulders Yvo M., Damman Olga C., Brouwers Corline, Rutten Guy E.H.M., Dorresteijn Jannick A.N. 16 Jul 2021, In: BMJ Open. 11 , p. 1-8

Person-centered diabetes care and patient activation in people with type 2 diabetes

Rutten Guy E. H. M., Van Vugt Heidi, de Koning Eelco 15 Dec 2020, In: BMJ open diabetes research & care. 8 , p. 1-8

Patient‐reported outcomes after 10‐year follow‐up of intensive, multifactorial treatment in individuals with screen‐detected type 2 diabetes::the ADDITION‐Europe trial

Dalsgaard E. M., Sandbæk A., Griffin S. J., Rutten G. E.H.M., Khunti K., Davies M. J., Irving G. J., Vos R. C., Webb D. R., Wareham N. J., Witte D. R. Sep 2020, In: Diabetic Medicine. 37 , p. 1509-1518 10 p.

Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years

Vos Rimke C., Den Ouden Henk, Daamen Lois A., Bilo Henk J.G., Denig Petra, Rutten Guy E.H.M. 31 Mar 2020, In: BMJ Open Diabetes Research and Care. 8 7 p.

Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes

Harris Stewart, Abrahamson Martin J., Ceriello Antonio, Charpentier Guillaume, Evans Marc, Lehmann Roger, Liebl Andreas, Linjawi Sultan, Holt Richard I.G., Hosszúfalusi Nóra, Rutten Guy, Vilsbøll Tina 1 Feb 2020, In: Drugs. 80 , p. 147-165 19 p.

Koolhydraatbeperkt dieet bij diabetes type 2 niet de enige weg

van Wijland Hans, Rutten Guy 1 Jan 2020, In: Huisarts en Wetenschap. 63 , p. 30-32 3 p.

Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care:10-year follow-up of the ADDITION-Europe cluster-randomised trial

Griffin Simon J., Rutten Guy E.H.M., Khunti Kamlesh, Witte Daniel R., Lauritzen Torsten, Sharp Stephen J., Dalsgaard Else Marie, Davies Melanie J., Irving Greg J., Vos Rimke C., Webb David R., Wareham Nicholas J., Sandbæk Annelli 1 Dec 2019, In: The Lancet Diabetes and Endocrinology. 7 , p. 925-937 13 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not